Treatment relative effect with 95% CI; and degree of certainty (adaptated from GRADE). method
| Treament | Trials | |||||
|---|---|---|---|---|---|---|
| clinical deterioration | clinical improvement | deaths | viral clearance | |||
| angiotensin receptor blockers (ARBs) | - | - | 1.02 [0.02; 52.15], 1 RCT, I2=0% inconclusive result | - | ||
| discontinuation of ACEI/ARB | - | - | 0.61 [0.24; 1.56], 1 RCT, I2=0% inconclusive result | - | ||
| angiotensin converting enzyme inhibitors (ACEIs) | 0 | - | - | - | - | |
| angiotensin-(1-7) | 0 | - | - | - | - | |
| continuation of ACEI/ARB | 0 | - | - | - | - | |
| RAS blocker withdrawal | 0 | - | - | - | - | |
| rhACE2 | 0 | - | - | - | - | |
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
